Showing results (41-50 of 54) with videos related to

Sort By:
Pageof 6
Cancer Research|July 29, 2010
Development of a novel tumor-targeted vascular disrupting agent activated by membrane-type matrix metalloproteinasesJennifer M Atkinson, Robert A Falconer, Dylan R Edwards, et al.
Molecular Cancer Therapeutics|December 10, 2009
In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenograftsKaye J Williams, Mark R Albertella, Brian Fitzpatrick, et al.
Scientific Reports|October 15, 2020
Application of small molecule FPR1 antagonists in the treatment of cancersDjevdet S Ahmet, Haneen A Basheer, Anwar Salem, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 22, 2005
Heparin octasaccharides inhibit angiogenesis in vivoJurjees Hasan, Steven D Shnyder, Andrew R Clamp, et al.
RSC Medicinal Chemistry|September 16, 2024
Sidechain structure-activity relationships of cyclobutane-based small molecule αvβ3 antagonistsAdam Throup, Manar Saleh Zraikat, Andrew Gordon, et al.
Scientific Reports|September 24, 2021
Cytochrome P450 isoforms 1A1, 1B1 AND 2W1 as targets for therapeutic intervention in head and neck cancerDaniela Presa, Syed A Khurram, Amir Z A Zubir, et al.
Journal of Medicinal Chemistry|July 13, 2013
Re-engineering of the duocarmycin structural architecture enables bioprecursor development targeting CYP1A1 and CYP2W1 for biological activityHelen M Sheldrake, Sandra Travica, Inger Johansson, et al.
Plos One|August 17, 2013
Pharmacological inhibition of polysialyltransferase ST8SiaII modulates tumour cell migrationYousef M J Al-Saraireh, Mark Sutherland, Bradley R Springett, et al.
Bioorganic & Medicinal Chemistry Letters|October 30, 2012
Synthesis and biological evaluation of colchicine C-ring analogues tethered with aliphatic linkers suitable for prodrug derivatisationJérémie Fournier-Dit-Chabert, Victoria Vinader, Ana Rita Santos, et al.
Pageof 6